OnDemand WTP Pricing Research

Eli Lilly CEO on Price Transparency, Loxo Acquisition [Video] | Bloomberg

Dave Ricks, chief executive officer at Eli Lilly, discusses drug price transparency, the purchase of Loxo Oncology, and adding to the company’s pipeline via acquisitions. He speaks with Bloomberg’s Taylor Riggs on “Bloomberg Markets.” (Source: Bloomberg)

Read complete article here:

Eli Lilly CEO on Price Transparency, Loxo Acquisition – Bloomberg.

Post a Comment

WP-SpamFree by Pole Position Marketing